| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3810/PGM.2009.01.1961 |
| P698 | PubMed publication ID | 19179820 |
| P50 | author | Michael S Benninger | Q89776261 |
| P2860 | cites work | Association between asthma and rhinitis according to atopic sensitization in a population-based study | Q48033561 |
| Using the congestion quantifier seven-item test to assess change in patient symptoms and their impact | Q48433159 | ||
| Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. | Q48452903 | ||
| Severity and impairment of allergic rhinitis in patients consulting in primary care | Q48518767 | ||
| Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. | Q49079002 | ||
| Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. | Q50940308 | ||
| Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. | Q51012036 | ||
| Adverse central nervous system effects of older antihistamines in children. | Q51578395 | ||
| Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. | Q51958666 | ||
| Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. | Q53520778 | ||
| Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. | Q53543750 | ||
| The development of the Rhinosinusitis Disability Index. | Q53588432 | ||
| Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease | Q28180460 | ||
| The diagnosis and management of rhinitis: an updated practice parameter | Q28288874 | ||
| Pathophysiology of the inflammatory response | Q33750651 | ||
| Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis | Q34083741 | ||
| Allergic rhinitis and its impact on asthma | Q34438438 | ||
| World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) | Q34589248 | ||
| Overview of comorbid associations of allergic rhinitis | Q34738178 | ||
| Intranasal corticosteroids for allergic rhinitis | Q34998096 | ||
| Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes | Q35210358 | ||
| The safety of intranasal steroids | Q35603365 | ||
| Techniques of intranasal steroid use. | Q35630770 | ||
| Allergic rhinitis: treatment based on patient profiles | Q36401937 | ||
| Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis | Q39337071 | ||
| Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms | Q39349296 | ||
| Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray | Q39395527 | ||
| Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine | Q39443746 | ||
| Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis | Q39475601 | ||
| Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis | Q39506183 | ||
| Observations on the pathogenesis of nasal priming | Q40771093 | ||
| Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis | Q42163736 | ||
| Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis | Q42556667 | ||
| A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis | Q43905718 | ||
| Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis | Q44147932 | ||
| Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis | Q44448788 | ||
| Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast | Q44458868 | ||
| Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis | Q44471863 | ||
| Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis | Q44778643 | ||
| Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis | Q45057566 | ||
| Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study | Q46227044 | ||
| Seasonal and perennial allergic rhinitis: is this classification adherent to real life? | Q46524669 | ||
| Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis | Q46563736 | ||
| A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis | Q46639885 | ||
| Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy | Q47866384 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nasal congestion | Q3245488 |
| P304 | page(s) | 122-131 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Postgraduate Medicine | Q7234297 |
| P1476 | title | Diagnosis and management of nasal congestion: the role of intranasal corticosteroids | |
| P478 | volume | 121 |
| Q93016483 | Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications | cites work | P2860 |
Search more.